.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Novartis
Accenture
Johnson and Johnson
Federal Trade Commission
UBS
Dow
US Army
Farmers Insurance
Cipla

Generated: December 14, 2017

DrugPatentWatch Database Preview

Promius Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for PROMIUS PHARMA, and when can generic versions of PROMIUS PHARMA drugs launch?

PROMIUS PHARMA has five approved drugs.

There are five US patents protecting PROMIUS PHARMA drugs.

There are five patent family members on PROMIUS PHARMA drugs in four countries.

Summary for Promius Pharma

International Patents:5
US Patents:5
Tradenames:5
Ingredients:5
NDAs:5
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Promius Pharma LlcSERNIVObetamethasone dipropionateSPRAY;TOPICAL208079-001Feb 5, 2016RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Promius Pharma LlcSERNIVObetamethasone dipropionateSPRAY;TOPICAL208079-001Feb 5, 2016RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Promius PharmaISMOisosorbide mononitrateTABLET;ORAL019091-001Dec 30, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Promius PharmaTENEXguanfacine hydrochlorideTABLET;ORAL019032-001Oct 27, 1986ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Promius Pharma LlcSERNIVObetamethasone dipropionateSPRAY;TOPICAL208079-001Feb 5, 2016RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Promius Pharma LlcCLODERMclocortolone pivalateCREAM;TOPICAL017765-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Promius PharmaTENEXguanfacine hydrochlorideTABLET;ORAL019032-002Nov 7, 1988ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Promius PharmaTENEXguanfacine hydrochlorideTABLET;ORAL019032-003Nov 7, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Promius Pharma LlcSERNIVObetamethasone dipropionateSPRAY;TOPICAL208079-001Feb 5, 2016RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Promius PharmaSECTRALacebutolol hydrochlorideCAPSULE;ORAL018917-003Dec 28, 1984ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Promius Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Promius PharmaTENEXguanfacine hydrochlorideTABLET;ORAL019032-003Nov 7, 1988► Subscribe► Subscribe
Promius PharmaSECTRALacebutolol hydrochlorideCAPSULE;ORAL018917-001Dec 28, 1984► Subscribe► Subscribe
Promius PharmaTENEXguanfacine hydrochlorideTABLET;ORAL019032-002Nov 7, 1988► Subscribe► Subscribe
Promius PharmaSECTRALacebutolol hydrochlorideCAPSULE;ORAL018917-003Dec 28, 1984► Subscribe► Subscribe
Promius PharmaTENEXguanfacine hydrochlorideTABLET;ORAL019032-001Oct 27, 1986► Subscribe► Subscribe
Promius PharmaSECTRALacebutolol hydrochlorideCAPSULE;ORAL018917-003Dec 28, 1984► Subscribe► Subscribe
Promius PharmaSECTRALacebutolol hydrochlorideCAPSULE;ORAL018917-001Dec 28, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Promius Pharma Drugs

Country Document Number Estimated Expiration
Japan2013503203► Subscribe
Japan5833007► Subscribe
Denmark2473161► Subscribe
World Intellectual Property Organization (WIPO)2011026076► Subscribe
European Patent Office3141246► Subscribe
European Patent Office2473161► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Medtronic
Express Scripts
Farmers Insurance
US Army
Citi
Argus Health
McKesson
Julphar
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot